Ligand Pharmaceuticals (LGND) Change in Inventory (2011 - 2026)

Ligand Pharmaceuticals has disclosed Change in Inventory across 16 years of filings, most recently posting $4.1 million for Q1 2026.

• Change in Inventory for Q1 2026 came in at $4.1 million, up 728.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.3 million (up 79.22% YoY), and the FY2025 annual result was -$5.0 million, up 48.14% from the prior year.
• Change in Inventory came in at $4.1 million for Q1 2026 at Ligand Pharmaceuticals, up from -$2.8 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $13.0 million in Q2 2023 to a low of -$9.7 million in Q2 2022.
• The 5-year median for Change in Inventory is -$1.4 million (2022), against an average of -$685588.2.
• Across the five-year window, Change in Inventory sank 4525.0% in 2023 and surged 728.0% in 2026, its largest moves.
• Ligand Pharmaceuticals' Change in Inventory stood at -$1.4 million in 2022, then soared by 47.86% to -$707000.0 in 2023, then tumbled by 262.94% to -$2.6 million in 2024, then slipped by 8.11% to -$2.8 million in 2025, then soared by 249.24% to $4.1 million in 2026.
• The last three Change in Inventory figures came in at $4.1 million (Q1 2026), -$2.8 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.